Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 9,662 | 9,935 | 7,425 | 8,244 | 8,193 |
| Operating Income | -9,662 | -9,935 | -7,425 | -8,244 | -8,193 |
| Interest Expense | 229 | 227 | 271 | 111 | 85 |
| Other Income | 278 | 230 | 476 | -165 | -171 |
| Pre-tax Income | -9,613 | -9,932 | -7,220 | -8,520 | -8,449 |
| Net Income Continuous | -9,613 | -9,932 | -7,220 | -8,520 | -8,449 |
| Net Income | $-9,613 | $-9,932 | $-7,220 | $-8,520 | $-8,449 |
| EPS Basic Total Ops | -0.16 | -0.17 | -0.12 | -0.14 | -0.15 |
| EPS Basic Continuous Ops | -0.16 | -0.17 | -0.12 | -0.14 | -0.14 |
| EPS Diluted Total Ops | -0.16 | -0.17 | -0.12 | -0.14 | -0.15 |
| EPS Diluted Continuous Ops | -0.16 | -0.17 | -0.12 | -0.14 | -0.14 |
| EBITDA(a) | $-9,655 | $-9,925 | $-7,414 | $-8,234 | $-8,183 |